BioCentury
ARTICLE | Financial News

Dynavax completes equity-based line of credit

September 27, 2010 7:00 AM UTC

Dynavax Technologies Corp. (NASDAQ:DVAX), Berkeley, Calif. Business: Inflammation, Infectious, Autoimmune Date completed: 9/20/10 Type: Equity-based line of credit Raised: $2 million Shares: 1 million...